Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
The PERSEVERE Study
NCT06588634 · View on ClinicalTrials.gov ↗
Study Summary
Randomized Controlled Trial of High-Risk Pulmonary Embolism Comparing FlowTriever System vs. Standard of Care
Conditions Studied
Interventions
- PROCEDURE Standard of Care
- DEVICE FlowTriever System
Study Locations (20)
Other
- Besançon University Hospital — Besançon
- Hopital Arnaud de Villeneuve, Montpellier — Montpellier
- CHU Nîmes Caremeau — Nîmes
- Hôpital Européen Georges-Pompidou, Paris — Paris
- Klinikum Chemnitz — Chemnitz
- Universitätsklinikum Carl Gustav Carus an der TU Dresden — Dresden
- Universitätsmedizin Mainz — Mainz
- Munich LMU — München
Florida
- Orlando Health Regional Medical Center — Orlando
- Sarasota Memorial Hospital — Sarasota
New York
- Northwell Health — Bay Shore
- SUNY, The University at Buffalo — Buffalo
Pennsylvania
- UPHS Penn Health System — Philadelphia
- Allegheny General Hospital — Pittsburgh
Texas
- HCA Medical City Heart & Spine — Dallas
- HCA Methodist Health San Antonio — San Antonio
Connecticut
- Yale University — New Haven
Georgia
- Emory University — Atlanta
Mississippi
- University of Mississippi Medical Center — Jackson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2024-12-16 |
| Est. Completion | 2027-08-31 |
| Phase | NA |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06588634
The ClinicalTrials.gov registry entry for NCT06588634 describes a study currently listed as recruiting. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Inari Medical, which has 5 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 2 conditions, with Pulmonary Embolism appearing as the primary indexed condition, and to 2 interventions — of which Standard of Care is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT06588634 reports 20 study locations spanning 9 distinct geographic areas — top geographies include Other, Florida, New York. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT06588634 about?
NCT06588634 is a clinical study titled "The PERSEVERE Study". Randomized Controlled Trial of High-Risk Pulmonary Embolism Comparing FlowTriever System vs. Standard of Care
What is the current status of trial NCT06588634?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2024-12-16. Estimated completion is 2027-08-31.
What conditions does trial NCT06588634 study?
This clinical trial studies the following conditions: Pulmonary Embolism, Pulmonary Thromboembolism. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT06588634?
The interventions under investigation include: Standard of Care (PROCEDURE), FlowTriever System (DEVICE). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT06588634?
This trial is sponsored by Inari Medical, which has 5 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT06588634 being conducted?
This trial has 20 study locations across Connecticut, Florida, Georgia, Mississippi, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.